Venture investor Krishna Yeshwant uses a healthy amount of skepticism when vetting potential companies to invest in. His favorite time to invest is when one of his partners at the fund is excited about a particular company, even if nobody else is.
{iframe}https://www.businessinsider.com/gvs-krishna-yeshwant-on-skepticism-in-biotech-and-healthcare-investments-2018-8{/iframe}